BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23210269)

  • 1. Naming drug substances at the national level: mainly in the United Kingdom and the United States.
    Prescrire Int; 2012 Nov; 21(132):279. PubMed ID: 23210269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Nonproprietary Names (INN) for pharmaceutical substances.
    Kopp-Kubel S
    Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstacles to the universal application of INNs.
    Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How INNs are created. Making drug names safer by contributing to INN selection.
    Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
    Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
    PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic drug names and social welfare.
    Lobo F; Feldman R
    J Health Polit Policy Law; 2013 Jun; 38(3):573-97. PubMed ID: 23418366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NONPROPRIETARY NAMES; NATIONAL AND INTERNATIONAL.
    JEROME JB; ALESSANDRI MC
    JAMA; 1965 May; 192():405-8. PubMed ID: 14282515
    [No Abstract]   [Full Text] [Related]  

  • 8. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
    Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
    MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The INN global nomenclature of biological medicines: A continuous challenge.
    Robertson JS; Chui WK; Genazzani AA; Malan SF; López de la Rica Manjavacas A; Mignot G; Thorpe R; Balocco R; Rizzi M
    Biologicals; 2019 Jul; 60():15-23. PubMed ID: 31130314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a New Stereochemically Informative Nonproprietary Drug Naming System.
    Gal J
    Pharmaceut Med; 2020 Apr; 34(2):113-126. PubMed ID: 32077042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing generic drugs using a generic name: Are we teaching it right?
    Kamath A
    Indian J Med Ethics; 2016; 1(3):194. PubMed ID: 27474700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
    Kwo EC; Kamat P; Steinman MA
    Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of the database on nonproprietary names of drugs].
    Hashiba S; Takenaka Y; Nakadate M
    Eisei Shikenjo Hokoku; 1989; (107):141-5. PubMed ID: 2636918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The INNs and outs of antibody nonproprietary names.
    Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
    MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Nonproprietary Names (INN). A World Health Organization activity.
    Jerome JB; Luback PM
    J Am Med Womens Assoc (1972); 1972 Oct; 27(10):536-8. PubMed ID: 4342347
    [No Abstract]   [Full Text] [Related]  

  • 16. Common stems: international nonproprietary names (INNs): common INN stems provide key information.
    Prescrire Int; 2007 Oct; 16(91):192. PubMed ID: 17926829
    [No Abstract]   [Full Text] [Related]  

  • 17. The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough.
    Loizides U; Dominici M; Manderson T; Rizzi M; Robertson JS; de Sousa Guimarães Koch S; Timón M; Balocco R
    Cytotherapy; 2021 May; 23(5):357-366. PubMed ID: 33820700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more.
    Parren PWHI; Carter PJ; Plückthun A
    MAbs; 2017; 9(6):898-906. PubMed ID: 28621572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naming of drugs. Differences between nomenclatures are much greater than editorial suggested.
    Navarro FA
    BMJ; 1996 Sep; 313(7058):688-9. PubMed ID: 8811773
    [No Abstract]   [Full Text] [Related]  

  • 20. Think INN, prescribe INN, dispense INN: good professional practice.
    Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.